|
MechanismCSF-1R antagonists |
|
|
|
|
Drug Highest PhaseApproved |
First Approval Ctry. / Loc.US |
First Approval Date14 Aug 2024 |
100 Clinical Results associated with South Texas Oncology & Hemetology PLLC
0 Patents (Medical) associated with South Texas Oncology & Hemetology PLLC
100 Deals associated with South Texas Oncology & Hemetology PLLC
100 Translational Medicine associated with South Texas Oncology & Hemetology PLLC